Fintel reports that on February 18, 2025, William Blair upgraded their outlook for Parsons (NYSE:PSN) from Market Perform to ...

Investment analysts at William Blair reduced their Q1 2025 EPS estimates for shares of Zoetis in a note issued to investors ...

William Blair raised their Q3 2025 earnings per share estimates for Cisco Systems in a note issued to investors on Thursday, ...

Fintel reports that on February 13, 2025, William Blair upgraded their outlook for Manhattan Associates (NasdaqGS:MANH) from ...

In a report released today, Sami Corwin from William Blair maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report). The ...

We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as the ...

William Blair downgraded Sprinklr (CXM) to Market Perform from Outperform without a price target after the company announced a 15% global ...

William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as ...

CHICAGO--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John ...

On Monday, William Blair reaffirmed a Market Perform rating on Kenvue Inc (NYSE:KVUE), a consumer health company with a market capitalization of $38.69 billion. According to InvestingPro data ...